Li Jing, Yang Jing, Feng Jiayu, Xu Xiaohui, Xu Tingling, Zhou Maigeng, Dong Wenlan, Zhang Yanbo
Department of Health Statistics, School of Public Health, Shanxi Medical University, Jinzhong, China.
Shanxi Provincial Key Laboratory of Major Diseases Risk Assessment, Shanxi Medical University, Jinzhong, China.
Glob Health Action. 2025 Dec;18(1):2543605. doi: 10.1080/16549716.2025.2543605. Epub 2025 Aug 20.
Diabetes is a leading global public health challenge with 537 million cases worldwide in 2021 and significant economic and societal burdens. Despite global initiatives, feasibility constraints limit widespread implementation of diabetes prevention/control measures. The key to facilitating the implementation of diabetes prevention and control measures lies in prioritise them.
This study aimed to determine the priority of diabetes prevention and control measures in China from the feasibility perspective.
From January to February 2021, an online survey was administered to professionals specifically responsible for implementing chronic disease prevention and control programs in 488 national demonstration areas in China. The survey assessed the importance and feasibility of 44 diabetes prevention and control measures across 10 dimensions. The Importance-Performance Analysis (IPA) model categorized these indicators into four quadrants: Highest Priority (high importance and feasibility), Priority Improvement (high importance, low feasibility), Lowest Priority (low importance and feasibility), and Secondary Improvement (low importance, high feasibility).
Quadrant 1 ('Highest Priority') included health education, community action, high-risk discovery and intervention, and medical insurance and family doctors, which should be maintained and strengthened. Quadrant 2 ('Priority Improvement') included patient management and complication screening, necessitating targeted efforts to enhance implementation. Quadrant 3 ('Lowest Priority') included personal health services assessment follow-up, environmental support, sugar reduction policy, and diabetes co-infection prevention, indicating a risk of overinvestment. No indicators were categorized into Quadrant 4 ('Secondary Priority').
Prioritizing diabetes prevention and control measures based on feasibility maximizes the utilization of limited resources, providing implementable recommendations for policymakers.
糖尿病是一项重大的全球公共卫生挑战,2021年全球有5.37亿病例,并带来了巨大的经济和社会负担。尽管有全球倡议,但可行性限制阻碍了糖尿病预防/控制措施的广泛实施。促进糖尿病预防和控制措施实施的关键在于对其进行优先排序。
本研究旨在从可行性角度确定中国糖尿病预防和控制措施的优先级。
2021年1月至2月,对中国488个国家示范区中专门负责实施慢性病预防和控制项目的专业人员进行了在线调查。该调查评估了44项糖尿病预防和控制措施在10个维度上的重要性和可行性。重要性-绩效分析(IPA)模型将这些指标分为四个象限:最高优先级(高重要性和可行性)、优先改进(高重要性,低可行性)、最低优先级(低重要性和可行性)和次要改进(低重要性,高可行性)。
第一象限(“最高优先级”)包括健康教育、社区行动、高危人群发现与干预以及医疗保险和家庭医生,应予以维持和加强。第二象限(“优先改进”)包括患者管理和并发症筛查,需要有针对性地努力加强实施。第三象限(“最低优先级”)包括个人健康服务评估随访、环境支持、减糖政策和糖尿病合并感染预防,表明存在过度投资的风险。没有指标被归类到第四象限(“次要优先级”)。
基于可行性对糖尿病预防和控制措施进行优先排序可最大限度地利用有限资源,为政策制定者提供可实施的建议。